Authors
Latest:
The Incidence and Costs of Hypoglycemia in Type 2 DiabetesThe overall incidence of hypoglycemia was considerable in this large working-age population and was associated with $52 million (2008 dollars) in direct medical costs.
Latest:
False Activation of the Cardiac Catheterization Laboratory for Primary PCIBetween 2005 and 2011, rates of cardiac catheterization laboratory false activation doubled while mean door-to-balloon times for primary PCI declined.
Latest:
Cost Analysis Review of Stroke Centers, Telestroke, and rt-PAUse of rt-PA is associated with long-term cost savings, but more high-quality, current cost-effectiveness research is needed for stroke centers, care networks, and telemedicine.
Latest:
A Systematic Review of Measurement Properties of Instruments Assessing PresenteeismA systematic review of presenteeism instruments found that most have been validated to some extent, but evidence for criterion validity is virtually absent.
Latest:
Curtailing Utilization of Low-Value Medical CareWorking together to reduce low-value care, stakeholders can help eliminate wasteful spending and deliver on their goal to improve the health of Americans by delivering higher-quality care at lower cost.
Latest:
Medicare Beneficiaries’ Out-of-Pocket Costs for Commonly Used Generic Drugs, 2009-2017Out-of-pocket costs required by Medicare prescription drug plans for drugs available through Walmart’s generic drug discount program have decreased from 2009 to 2017.
Latest:
Comparison of the Use of Top-Ranked Cancer Hospitals Between Medicare Advantage and Traditional MedicareMedicare Advantage enrollees, particularly those with lower out-of-network benefits, may have restricted access to top-ranked hospitals for complex cancer care compared with traditional Medicare enrollees.
Latest:
Cost-effectiveness Evaluation of a Home Blood Pressure Monitoring ProgramA technology-based, pharmacist-run home blood pressure monitoring program improves health outcomes by investing $20.50 per mm Hg systolic blood pressure lowered and $3300 per life-year gained.
Latest:
Prevalence, Effectiveness, and Characteristics of Pharmacy-Based Medication Synchronization ProgramsThis study evaluates the prevalence, structure, and key features of pharmacy-based programs to synchronize prescription fill dates, about which, little is known.
Latest:
The Impact of Kaua'i Care Transition Intervention on Hospital Readmission RatesBy enrolling selected high-risk elderly patients into the intervention, then empowering and educating them, this study successfully reduced hospital readmission rates.
Latest:
COPD Exacerbation Costs in the IMPACT Study: A Within-Trial AnalysisTreatment with fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) compared with FF/VI or UMEC/VI reduced exacerbation-related costs associated with chronic obstructive pulmonary disease (COPD) in the US healthcare system.
Latest:
Meeting the Measure: Improving ADHD Care in the Medical HomeQuality improvement methodology was implemented to ensure that patients receiving medications for attention-deficit/hyperactivity disorder (ADHD) returned for an appointment within 30 days of initiating medication.
Latest:
Late Diagnosis of Hepatitis C Virus Infection, 2014-2016: Continuing Missed Intervention OpportunitiesLate hepatitis C virus infection diagnosis points to a need for earlier screening and treatment before the onset of severe liver disease leading to high cost and diminished outcomes.
Latest:
Cost of Home vs Clinic Administration of Paclitaxel in Metastatic Breast CancerHome administration of oral paclitaxel and encequidar is associated with potential cost savings for payers compared with clinic administration of intravenous chemotherapy in metastatic breast cancer patients.
